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Abstract
Background: The use of antithrombotic therapy (anticoagulants and/or antiplatelets) in the setting of traumatic
cervical arterial dissection (CAD) for the prevention of stroke remains controversial. This issue is further complicated
by the frequent co-existence of intracranial hemorrhage (ICH) and other intracranial injuries, and also the wide
variability in treatment due to a lack of evidence-based guidance. To address these controversies, a registry in a
major Level I trauma center was created. The purpose of this investigation was to compare the safety of
antithrombotic therapy in post-traumatic CAD. Analysis from the first year is presented.
Methods: All cervical dissections from the year 2005 were identified in patients at least 18 years of age by
diagnosis code from radiology and trauma databases. Presence of arterial injury and grade, and other intracranial
disease or injury such as stroke was diagnosed by a trauma radiologist and adjudicated by a neuroradiologist.
Results: Fifty-five patients with cervical artery dissection were identified. Fourteen patients presented with a total
of 20 acute, post-traumatic intracranial hemorrhages (ICH). Seven of the 14 patients with ICH were treated with
antithrombotic therapy, and none extended their intracranial hemorrhages. Of the 41 patients without pre-existing
ICH, 28 were treated with antithrombotic therapy and only one developed an interval hematoma. Among all 55
cases, two patients developed an acute ischemic stroke in the territory of the dissected artery after admission; both
patients were in the untreated group.
Conclusion: In so far as antithrombotic therapy may offer benefit in preventing early ischemic stroke following
cervical artery dissection, these data suggest withholding antiplatelet or other antithrombotics following trauma
may not be warranted, even in the setting of intracranial hemorrhage. From a safety perspective, this registry-
based case series indicates antithrombotic management of arterial injury did not contribute to development or
progression of ICH, even in patients with pre-existing ICH. This data suggest that instituting early antithrombotic
therapy presents a low risk of ICH or hemorrhage extension among traumatic cervical dissection patients.
Background
Cervical arterial injuries can occur after blunt trauma,
a n da r eo f t e ns e e ni nt h es e t t i n go fwhiplash injuries
resulting from forced neck flexion and extension. Such
injuries are a well-recognized risk factor for ischemic
stroke secondary to either artery to artery embolic phe-
nomena, or from hemodynamic compromise due to
luminal stenosis or occlusion [1,2]. Dissection accounts
for approximately 2% of all ischemic stroke, but perhaps
as much as 20% of ischemic stroke in patients less than
45 years of age [3,4]. Although the incidence of all trau-
matic cervical arterial injuries is unknown, the estimated
incidence of carotid dissection is 0.08% of all blunt trau-
mas [5] and 0.67% of MVA-related blunt trauma [6].
The combined incidence of carotid and vertebral injury,
also known as blunt cerebrovascular injury (BCVI), is
estimated at 1% of all blunt traumas [7]. With the
increased use of multi-detector computer tomography,
identification of these injuries is becoming more
common.
Much of the current literature on the natural history
of dissection and stroke focuses on therapy for
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tion [8-11]. Ischemic stroke, primarily from artery to
artery emboli after arterial injury, can occur at any time
a f t e ri n j u r y ,b u ti sm o s tf r e q u e n ti nt h ef i r s t7d a y s
[12,13]. The timing and use of antithrombotic therapy,
including both anticoagulants and antiplatelets, for
stroke prevention in dissection remains controversial
due to the absence of prospective randomized clinical
trials. The appropriate use of antithrombotic therapy is
even less clear in trauma patients, who frequently have
other serious injuries associated with increased hemor-
rhage risk. Our group initiated a registry for the meth-
odologies of identification, treatment, and outcome of
cervical dissection at a Level I trauma center. Data from
the first year is presented.
Methods
Study Design and Case Identification
The R. Adams Cowley Shock Trauma Center is a Level I
trauma center in Baltimore, MD, which receives approxi-
mately 8,265 patient visits annually. Trauma patients are
routinely screened within 6 hours of admission for vascu-
lar injury utilizing an intravenous contrast-enhanced
whole-body multi-detector computed tomography scan-
ning protocol. All dissections in patients at least 18 years
of age during 2005 were identified by diagnosis code
(either carotid or vertebral dissection) from Radiology and
Trauma databases populated from the multi-detector CT
results. A consecutive, case series was collected in a retro-
spective manner from chart review. Presence of arterial
injury, ischemic or hemorrhagic stroke, and other intracra-
nial disease or injury was diagnosed by a trauma radiolo-
gist and adjudicated by a neuroradiologist. This protocol
was approved by University of Maryland, Baltimore Insti-
tutional Review Board prior to study commencement.
Data Collection and Outcomes Measures
Charts of identified subjects were reviewed with empha-
sis on discharge summaries, physical therapy notes and
follow-up clinic visits. All data were abstracted using a
standardized data collection form. Information on
demographics and mechanism of injury were obtained
from admission notes. Locations and grade of injury
were obtained from radiology reports and verified by a
neuroradiologist. Information regarding antithrombotic
therapy treatment and type, as well as hospital course
and interim complications, were noted from discharge
summaries. Outcomes were quantified by calculating a
Glasgow Outcome Score (GOS) ranging from 2 (persis-
tent vegetative state) to 5 (good recovery) as assessed at
a follow up clinic appointment closest to twelve weeks
from the injury. Cases were assigned a 5 if the subject
could resume normal occupational and social activities,
4 if the subject was independent but unable to resume
prior activities, 3 if partially or totally dependent on
other for activities of daily living, and 2 if the subject
was unaware of surroundings or unable to respond to
stimuli [14].
All data were entered in a database (MS Excel, Red-
mond, WA) and data were analyzed using SAS statistical
software, version 9.1 (SAS Institute, Cary, NC).
Results
In total, 55 patients with dissection were identified. Char-
acteristics of the study population in total and stratified
by whether the patient received antithrombotic therapy
are displayed in Table 1. Mean age was approximately 47
years and approximately 58% of the patients were male.
Among the 55 patients, there were 68 arterial dissections
of which 22 were vertebral, 44 were of the internal caro-
tid, and 2 were of the common carotid. Most patients’
injuries were the result of a motor vehicle crash and pre-
valence of hemorrhage on presentation was approxi-
mately 26%. Fourteen patients presented with a total of
20 post-traumatic hemorrhagic injuries including sub-
dural hematoma (n = 6), subarachnoid hemorrhage
(n = 9), intraparenchymal hemorrhage (n = 2), and intra-
ventricular hemorrhage (n = 3). Six of the 14 patients
had multiple types of hemorrhage.
Table 2 displays the distribution of treatment types
stratified by whether the patient had a hemorrhage on
initial CT scan. Seven of the 14 patients with a hemor-
rhage were treated with antithrombotic therapy (6 with
antiplatelets, and 1 with a combination of antiplatelets
and anticoagulation). Of the 41 patients without pre-
existing hemorrhage, 28 were treated with antithrombo-
tic therapy (22 with antiplatelets alone, 3 with anticoagu-
lation, and 3 with a combination of antiplatelets and
anticoagulation). None of the treated patients with
hemorrhage on initial presentation either extended their
hemorrhage or developed ischemic stroke. Of the 28
treated patients who did not a have a hemorrhage on pre-
sentation, only one developed interval ICH. This subject
presented with a left common carotid dissection and was
placed on aspirin, but subsequently suffered a cardiac
arrest from hemodynamic instability due to thoracic inju-
ries. He then developed extensive left hemispheric ICH
and subsequently expired. In summary, no treated patient
developed an ischemic stroke.
There were 20 patients that were not treated, 7 with pre-
existing ICH and 13 without pre-existing ICH. In total,
two untreated patients experienced ischemic strokes in
territories ipsilateral to the vascular injury. None of the
untreated group extended their hemorrhages. Patients
were not treated with antithrombotic agents to prevent
ischemic stroke for a variety of reasons, most commonly
due to rapid expiration shortly after presentation or due to
need for emergent surgical procedures.
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the non-treatment group (n = 20) and 6 of these within
the first 7 days of hospitalization. The subject who
expired in the treatment group presented with both an
ICH and SAH, and was treated with clopidogrel for a
left ICA dissection. While the patient experienced no
rebleeding as associated with therapy, a poor prognosis
led the patient’s family to electively withdraw care.
Among the patients that were not treated, 7 with pre-
existing ICH and 13 without pre-existing ICH, two
patients with pre-existing ICH died. One patient expired
secondary to cardiac arrest and the other patient from
brain herniation related to cerebral edema secondary to
anterior and middle cerebral artery infarction ipsilateral
to an internal carotid artery dissection.
Among patients alive at hospital discharge (n = 47), med-
ian (IQR) modified Rankin scores were 4 (1-5) and 2 (0-3)
in the treated and untreated groups respectively (Table 3).
Among the 47 patients discharged alive, 39 patients
returned to outpatient clinic for evaluation and 8 patients
were lost to outpatient follow up. Median Glasgow Out-
come Scores at three months were 4 (3-5) and 4 (4-5) in
the treated and untreated groups respectively (Table 3).
Discussion
We observed no hemorrhagic complications related to
stroke prevention with antithrombotic therapy in this
case series of cervical arterial dissection patients. Our
results are of interest in the trauma population, as there
is understandable reluctance for early treatment of these
injuries with anti-platelets or anticoagulation due to con-
cerns for promoting hemorrhage. Previous small,
retrospective studies have suggested both anti-platelets
and anticoagulants are safe for use in arterial dissection
[2], but no distinction was made between traumatic
dissection and spontaneous dissection in those trials.
Regarding trauma patients, a case series by Fabian et al.
evaluating blunt cerebrovascular injury demonstrated 2
of 47 patients receiving heparin developed subdural
hematomas requiring evacuation and one patient
had worsening intraventricular hemorrhage requiring
decreased heparin dose. All three made uneventful recov-
eries after these complications [6]. Cothren et al. reported
only 2 patients developing complications from treatment
in their series of 73 blunt carotid injuries receiving
antithrombotic therapy, namely visceral bleeding in
both cases. The authors suggest more aggressive anti-
coagulation protocols might be used based on this obser-
vation, although cases of intracranial hemorrhage were
excluded from the treatment group [15].
Our case series is unique in than it represents one of the
larger case series of traumatic cervical dissection in the lit-
erature, and includes patients with intracranial hemor-
rhage in the treatment group. Additionally, given that the
majority of ischemic strokes occur early in the course of
arterial dissection, most often in the first week, our
method of case review and follow-up would have identi-
fied such events. As such, we are confident that no
Table 1 Characteristics of the Study Population
Treatment (n = 35) No Treatment (n = 20) All (n = 55)
Age, mean (SD) 47.7 (18.7) 46.1 (19.1) 47. 1(18.7)
Male Sex, n (%) 18 (51.4) 14 (70.0) 32 (58.2)
Location of Arterial Injury†
Common Carotid 2 0 2
Internal Carotid 29 15 44
Vertebral 14 8 22
Mechanism of Injury, n (%)
Motor Vehicle Crash 30 (85.7) 15 (75.0) 45 (81.8)
Fall 4 (11.4) 4 (20.0) 8 (14.6)
Other 1 (2.9) 1 (5.0) 2 (3.6)
Hemorrhage on Presentation* 7 (20.0) 7 (35.0) 14 (25.5)
GCS on Presentation, median (IQR) 15 (6-15) 13.5 (3.5-15.0) 15 (6-15)
SD: standard deviation; GCS: Glasgow Coma Score; IQR: interquartile range.
†Among the 55 patients, there were 68 arterial injuries and 1 aneurysm.
* 14 patients presented with a total of 20 intracranial hemorrhages (ICH), specifically subdural hematoma (n = 6), subarachnoid hemorrhage (n = 9),
intraparenchymal hemorrhage (n = 2), or intraventricular hemorrhage (n = 3).
Table 2 Type of treatment by presence or absence of hemorrhage on presentation (n = 55)
Hemorrhage on presentation (n) Anti-platelet only n (%) Anti-coagulant only n (%) Combination therapy n (%) No treatment n (%)
Yes (14) 6 (42.9) 0 1 (7.1) 7 (50.0)
No (41) 22 (53.7) 3 (7.3) 3 (7.3) 13 (31.7)
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throughout the hospitalization and follow-up period.
A major limitation of our study was the lack of standar-
dized protocols regarding the timing, dosing, and selec-
tion of the antithrombotic agents implemented. Patient
selection and the decision to use (or not use) antithrom-
botic therapy was performed at the discretion of the
treating physician, and often a rationale was not noted.
The focus of this study was intracranial complications as
related to dissections or from antithrombotic therapy, as
such, subjects may have experienced hemorrhage in
other locations, such as GI bleeding, that was not cap-
tured in this analysis. However all in hospital deaths were
identified. Another limitation of the study is the small
number of study subjects, particularly among those that
received only anticoagulation and/or combination ther-
apy, as we only identified seven such individuals. Given
this limitation we urge the reader caution when inter-
preting these specific results. Nonetheless we felt it was
important to include this information for completeness
and to demonstrate that such therapies are implemented
in practice. Lastly, our study did not consider the effects
of other potential conditions in this cohort that might
affect hemorrhagic risk; these might include the size of
initial hemorrhage, coagulopathies from infection, meta-
bolic disturbances, end-organ damage, perisurgical risks,
or the use of LMWH for DVT prophylaxis. Future work
should include protocols for patient inclusion and exclu-
sion from antithrombotic therapy as well as standardized
medication timing and dosing. All hemorrhagic compli-
cations, both CNS and otherwise, should be recorded
during hospitalization and follow-up.
Conclusion
In so far as antithrombotic therapy may offer benefit in
preventing early ischemic stroke following cervical artery
dissection, these data suggest withholding antiplatelet or
other antithrombotics following trauma may not be
warranted, even in the setting of intracranial hemorrhage.
From a safety perspective, this registry-based case series
indicates antithrombotic management of arterial injury did
not contribute to development or progression of ICH,
even in patients with pre-existing ICH. Our data suggests
that early therapy might be safe in trauma patients from
the perspective of worsening intracranial injury.
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